Language

News topic

ATC group ATC B01

Current shortage notices for the ATC group ATC B01, structured by product, country and reporting period.

29 notices

← All shortages

What the ATC B01 notices indicate for the supply chain

The 29 consolidated notices from Austria, Czechia, Belgium, Germany are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Czechia

ANTITHROMBIN III BAXALTA 50IU/ML INF PSO LQF 1+1X20ML

Active ingredient: ANTITROMBIN III

View notice details →
Belgium

Dabigatran Etexilate Viatris 110 mg hard caps. 180

Active ingredient: Dabigatran Etexilate

View notice details →
Austria

Rivaroxaban +pharma 2,5 mg Filmtabletten

Active ingredient: RIVAROXABAN

View notice details →
Austria

Dabigatranetexilat 1A Pharma 150 mg - Hartkapseln

Active ingredient: DABIGATRANETEXILATMESILAT

View notice details →
Austria

Rivaroxaban Genericon 2,5 mg Filmtabletten

Active ingredient: RIVAROXABAN

View notice details →
Belgium

Clopidogrel Viatris 75 mg film-coat. tabl. 90

Active ingredient: Clopidogrel

View notice details →
Belgium

Urokinase Syner-Medica 100 000 IU inj./inf. sol. (pwdr.) i.v. vial 100000 IU

Active ingredient: Urokinase

View notice details →
Belgium

Cardioaspirine 100 mg maagsapresist. tabl. 84

Active ingredient: Acetylsalicylic Acid

View notice details →
Belgium

Urokinase Syner-Medica 100 000 IE inj./inf. opl. (pdr.) i.v. flac. 100000 IE

Active ingredient: Urokinase

View notice details →
Belgium

Rivaroxaban Viatris 15 mg - 20 mg filmomh. tabl. 49 (42 (15 mg) + 7 (20 mg))

Active ingredient: Rivaroxaban; Rivaroxaban

View notice details →
Czechia

CLOPIDOGREL VIATRIS 75MG TBL FLM 90 I

Active ingredient: KLOPIDOGREL

View notice details →
Belgium

Aggrastat 0.05 mg/ml inf. opl. i.v. 250 ml

Active ingredient: Tirofiban

View notice details →
Germany

Aggrastat 50 Mikrogramm/ml Infusionslösung

Active ingredient: Tirofibanhydrochlorid-Monohydrat

View notice details →
Germany

Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen

Active ingredient: Rivaroxaban

View notice details →
Austria

Dabigatranetexilat Viatris 150 mg Hartkapseln

Active ingredient: DABIGATRANETEXILATMESILAT

View notice details →
Austria

Rivaroxaban ratiopharm 20 mg Filmtabletten

Active ingredient: RIVAROXABAN

View notice details →
Austria

Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen

Active ingredient: RIVAROXABAN

View notice details →
Belgium

Clexane 2 000 IU (20 mg)/0,2 ml inj. opl. i.v./s.c. voorgev. spuit 10 x 0.2 ml UD

Active ingredient: Enoxaparin Sodium

View notice details →
Germany

Aggrastat 250 Mikrogramm/ml Konzentrat zur Herstellung einer Infusionslösung

Active ingredient: Tirofibanhydrochlorid-Monohydrat

View notice details →
Austria

Clopidogrel Krka d.d. 75 mg Filmtabletten

Active ingredient: CLOPIDOGREL

View notice details →
Austria

Aggrastat 50 Mikrogramm/ml - Infusionslösung

Active ingredient: TIROFIBAN HYDROCHLORID

View notice details →
Austria

Dabigatranetexilat 1A Pharma 110 mg - Hartkapseln

Active ingredient: DABIGATRANETEXILATMESILAT

View notice details →